<DOC>
	<DOCNO>NCT01008397</DOCNO>
	<brief_summary>Objectives : A ) To gather pharmacodynamic measurement assess blood level active ingredient AHIST dosage interval period 12 hour . Hypothesis : Hysteresis curve plot active ingredient 's blood level 12-hour dosage interval substantiate S5 Symptom Diary score ( IE : evidentiary therapeutic window data ) ; B ) To report subjective score subject rating efficacy single dose AHIST relieve nasal congestion , rhinorrhea , nasal itching , sneeze , post-nasal drip 12-hour dosage interval . Hypothesis : Greater 66 % subject document clinically significant relief 12-hour period one dose AHIST ; C ) Report side effect adverse drug reaction rate severity incidence . Hypothesis : Not one patient adverse event significant enough warrant withdrawal ; side effect mild frequently report side effect occur less 10 % patientsâ€”drowsiness .</brief_summary>
	<brief_title>Study AHIST Seasonal Allergic Rhinitis Patients</brief_title>
	<detailed_description>This Phase 1 clinical trial single dose pharmacokinetics study comprise 21 individual five blood draw 12 hour period . Additionally , subject subjectively score symptom relief report side effect single dose AHIST . Schulman Associates Institutional Review Board ( Cincinnati , OH ) approve study protocol statement inform consent . Each study participant give write informed consent ( See Attachment A ) . Safety assure close observation physical examination subject , study conclusion . This interventional study conduct spring allergy season 2010 . MAGNA plan show chlorpheniramine tannate safe effective B.I.D . drug treatment regimen , `` indicated relief symptom associate seasonal allergic rhinitis adult child 12 year age old . Treated symptom include nasal congestion , sneeze , rhinorrhea , itchy nose , itchy/watery eye , post nasal drip syndrome [ reduction tickly cough ( acute chronic ) , mucus back throat , sore throat , hoarseness ] . ''</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<criteria>1 . Male female ethnic group 18 60 year age . 2 . History moderate severe Seasonal Allergic Rhinitis ( SAR ) least two year . 3 . Subjects ' symptom result irritation sinus , nasal upper respiratory tract tissue include five symptom ( `` S5 '' ) focus study : nasal congestion , rhinorrhea , nasal itching , sneeze , post nasal drip . 4 . Prior study drug administration , subject ' good health confirm medical history , physical examination , urine dip pregnancy test . 5 . Allergic hypersensitivity confirm appropriate test deem necessary physician well establish patient medical history . 1 . Pregnancy lactation . 2 . Immunotherapy unless stable maintenance dose . 3 . Presence medical condition might interfere treatment evaluation require change therapy include limited high blood pressure urinary retention problem . 4 . Alcohol dependence . 5 . Use investigational drug previous month . 6 . Subjects present asthma require corticosteroid treatment . 7 . Subjects multiple drug allergy . 8 . Subjects know idiosyncratic reaction ingredient AHIST .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Rhinitis , Allergic , Seasonal</keyword>
</DOC>